Drugs / RECANACLOTIDE
RECANACLOTIDE
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02289846 | Oct 2014 → Dec 2015 | gastroparesis | Ironwood Pharmaceuticals, Inc. | Completed | Missed primary |
| Phase 2 | NCT01712412 | Oct 2012 → Feb 2014 | dyspepsia | Ironwood Pharmaceuticals, Inc. | Terminated | No outcome recorded Stop: Enrollment |
News releases announcing trial results or a regulatory action · 3
| Date | Issuer | Release |
|---|---|---|
| 2016-04-05 | Ironwood Pharmaceuticals, Inc. | Results Ironwood Pharmaceuticals Reports Top-Line Data from Exploratory Phase IIa Study of IW-9179 in Diabetic Gastroparesis ironwoodpharma.com ↗ |
| 2015-05-13 | Ironwood Pharmaceuticals, Inc. | Results Ironwood Presents Gastrointestinal Disease Research at Digestive Disease Week® 2015 ironwoodpharma.com ↗ |
| 2014-10-20 | Ironwood Pharmaceuticals, Inc. | Results Ironwood Presents IW-9179 Phase IIa Data at American College of Gastroenterology 2014 Annual Scientific Meeting ironwoodpharma.com ↗
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) announced today the presentation of initial data from a Phase IIa clinical study in functional dyspepsia with IW-9179, an investigational guanylate cyclase-C (GC-C) agonist designed to target the upper gastrointestinal (GI) tract. |
All press releases naming this drug 4 releases
| Date | Issuer | Release |
|---|---|---|
| 2016-04-05 | Ironwood Pharmaceuticals, Inc. | Ironwood Pharmaceuticals Reports Top-Line Data from Exploratory Phase IIa Study of IW-9179 in Diabetic Gastroparesis ironwoodpharma.com ↗ |
| 2015-05-13 | Ironwood Pharmaceuticals, Inc. | Ironwood Presents Gastrointestinal Disease Research at Digestive Disease Week® 2015 ironwoodpharma.com ↗ |
| 2014-12-09 | Ironwood Pharmaceuticals, Inc. | Ironwood Pharmaceuticals Initiates Phase IIa Clinical Study of IW-9179 in Diabetic Gastroparesis ironwoodpharma.com ↗ |
| 2014-10-20 | Ironwood Pharmaceuticals, Inc. | Ironwood Presents IW-9179 Phase IIa Data at American College of Gastroenterology 2014 Annual Scientific Meeting ironwoodpharma.com ↗ |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RECANACLOTIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL3707244 ↗ |
| Known as | IW-9179 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02289846 ↗ |
| Known as | Recanaclotida | ChEMBL registry synonym — accepted as the source's own label CHEMBL3707244 ↗ |
| Modality | Protein / enzyme biologic | — CHEMBL3707244 ↗ |
| Route | Oral | “Oral IW-9179 taken daily for two weeks” NCT01712412 ↗ |